Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy

מאת Baker, Matthew, Chaichian, Yashaar, Genovese, Mark, Derebail, Vimal, Rao, Panduranga, Chatham, Winn, Bubb, Michael, Lim, Sam, Hajian, Hooman, Gurtovaya, Oksana, Patel, Uptal, Tumlin, James
הוצא לאור ב RMD Open (2020)